Chris Schott
Chris Schott
lack patent portfolio top
It is our top pick. I like the lack of patent expirations... They have a portfolio of new products.
lack patent portfolio top
It is our top pick. I like the lack of patent expirations...They have a portfolio of new products.
addressing concerns december direction following increase sign step view
We view this announcement, following Pfizer's 26% dividend increase in December 2005, as another sign that Pfizer is addressing shareholder concerns and as another step in the right direction for the company.